Medical economics

German vaccine maker CureVac surges almost 250% in Nasdaq debut

Shares of German biotech company CureVac, which is developing a leading coronavirus vaccine candidate, rocketed Friday in its first day of trading in New York after raising more than $200 million in an initial public offering.

Diseases, Conditions, Syndromes

Germany takes stake in vaccine firm CureVac

Berlin will take a stake in German biotech company CureVac, Economy Minister Peter Altmaier said Monday, months after reports the US was eyeing the firm and its under-development coronavirus vaccine.

Medical research

Understanding how bone-dissolving cells are generated

Bone-dissolving cells called osteoclasts are derived from a type of immune cells called macrophages. They are necessary for the maintenance and renewal of bones. But the intracellular mechanisms through which macrophages ...

page 1 from 18

Messenger RNA

Messenger ribonucleic acid (mRNA) is a molecule of RNA encoding a chemical "blueprint" for a protein product. mRNA is transcribed from a DNA template, and carries coding information to the sites of protein synthesis: the ribosomes. Here, the nucleic acid polymer is translated into a polymer of amino acids: a protein. In mRNA as in DNA, genetic information is encoded in the sequence of nucleotides arranged into codons consisting of three bases each. Each codon encodes for a specific amino acid, except the stop codons that terminate protein synthesis. This process requires two other types of RNA: transfer RNA (tRNA) mediates recognition of the codon and provides the corresponding amino acid, while ribosomal RNA (rRNA) is the central component of the ribosome's protein manufacturing machinery.

This text uses material from Wikipedia, licensed under CC BY-SA